Biogen Inc.

BIIBNASDAQHealthcare● Active

$192.62

$-2.72(-1.39%)

Market Cap$28.4B

P/E Ratio—

52W High$205.97

52W Low$121.05

Avg Volume1.2M

Open$197.25

Beta0.18

Overview

Biogen Inc. (BIIB) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BIIB · net income · updated Jun 10, 2026

Core profitability metrics

BIIB · net income · margin · TTM · CAGR

Net income was $1.29B for FY2025 (fiscal year ending 2025-12-31), down 20.8% year-over-year. Net profit margin was 13.2%. Based on available data, Biogen Inc. has been profitable since at least 2011.

FY2025 Net Income$1.29B▼ -20.8% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin13.2%$1.29B ÷ $9.81B

YoY Change-20.8%—

5-Year CAGR-20.2%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 10, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · BIIB net income history · BIIB profit margin

Annual net income data

BIIB · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$1.29B▼ 20.8%13.2%$9.81B

FY2024$1.63B▲ +40.6%16.9%$9.68B

FY2023$1.16B▼ 61.9%11.8%$9.84B

FY2022$3.05B▲ +95.8%29.9%$10.17B

FY2021$1.56B▼ 61.1%14.2%$10.98B

Net income vs peers (Healthcare)

BIIB vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Biogen Inc. (BIIB) reported net income of $1.29B for FY2025 (fiscal year ending 2025-12-31), down 20.8% year-over-year. The net profit margin was 13.2% — meaning the company kept $0.13 of every dollar of revenue as profit.

Based on available data, Biogen Inc. has been profitable since at least 2011. Net income reached a peak of $5.89B in FY2019. Data available for 15 fiscal years.

Biogen Inc.'s net profit margin was 13.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Biogen Inc. net worth" — the company's market capitalization is a separate figure from BIIB net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BIIB net income · 5 questions

Biogen Inc. is profitable. The company reported net income of $1.29B for FY2025, a net profit margin of 13.2%. Net income was down 20.8% year-over-year. Based on available data, Biogen Inc. has been profitable since at least 2011.

is BIIB profitabledoes BIIB make a profitBIIB profitabilityBIIB profitable company

▸ Source: FMP /income-statement · GAAP · Biogen Inc. · Biogen Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 10, 2026